 |
市场调查报告书
商品编码
1671919
无导线心律调节器市场按产品类型、类型、最终用户和地区划分Leadless Pacemakers Market, By Product Type, By Type, By End User, By Geography |
||||||
2025 年全球无导线心律调节器市场规模估计为 8.041 亿美元，预计到 2032 年将达到 19.652 亿美元，2025 年至 2032 年的复合年增长率为 13.6%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 8.041亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年复合年增长率： | 13.60％ | 2032 年价值预测 | 19.652亿美元 |
无导线心律调节器是一种先进的心臟心律调节器，透过股动脉或经皮途径植入心臟，而不是透过胸部切口。与传统心律调节心律调节器不同，传统心律调节器植入胸部皮下，并透过电线从心律调节心律调节器连接至心臟，无导线心律调节器则直接植入心臟，无需电线。其益处包括减少与心律调节器导线相关的併发症，并提高患者接受磁振造影（MRI）扫描的资格。由于电子设备的小型化和电池寿命的提高，无导线心律调节器在治疗心搏过缓方面越来越受欢迎。预计未来几年全球对无导线心律调节器的需求将大幅成长。
市场动态：
全球无导线心律调节器市场的发展受到全球老龄人口不断增加的推动，老年人口更容易患心血管疾病，技术进步使得心律调节器系统小型化，以及无导线系统与传统心律调节器相比具有的优势，例如併发症更少、能够兼容磁振造影(MRI)。然而，与传统心律调节器相比，无导线心律调节器的成本较高，且电池寿命问题限制了市场的发展。具有更长电池寿命的完整无导线起搏系统的引入代表着一个巨大的成长机会。从地区来看，北美和欧洲的新兴市场目前占据市场主导地位，而亚太地区的新兴市场预计将在未来几年提供高成长机会。
本研究的主要特点
本研究报告对全球无导线心律调节器市场进行了详细分析，并给出了预测期（2025-2032）的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、性能和策略等参数，介绍了全球无导线心律调节器市场的主要企业概况。
研究中涉及的主要企业包括雅培实验室、美敦力公司、波士顿科学公司、EBR 系统公司、微创科学公司、Biotronik SE &Co.KG、圣犹达医疗公司（现为雅培的一部分）、Osypka AG、乐普医疗科技、心臟节律管理公司（CRM）、AtriCure 公司、库克医疗、索林集团、Bioscova Cure 公司、Bioscova 公司、Bioscova、索林集团、Bioscova 公司。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球无导线心律调节器市场的各种策略矩阵来更轻鬆地做出决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
4. 2020 年至 2032 年全球无导线心律调节器市场（依产品类型）
- Micra 经导管心律调节系统
- NanoStim无导线心律调节器
- 其他无导线心律调节器
5. 2020 年至 2032 年全球无导线心律调节器市场（按类型）
- 单室
- 双腔室
6. 2020 年至 2032 年全球无导线心律调节器市场（依最终用户划分）
- 医院
- 门诊手术中心
- 长期照护机构
- 其他的
7. 全球无导线心律调节器市场（按地区划分），2020 年至 2032 年
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第八章 竞争格局
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- EBR Systems Inc.
- MicroPort Scientific Corporation
- Biotronik SE & Co. KG
- Jude Medical（现归雅培所有）
- Osypka AG
- Lepu Medical Technology
- Cardiac Rhythm Management（CRM）
- AtriCure Inc.
- Cook Medical
- Sorin Group
- Biotronik
- Neovasc Inc.
第 9 章分析师建议
- 命运之轮
- 分析师观点
- 一致的机会地图
第十章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
The Global Leadless Pacemakers Market is estimated to be valued at USD 804.1 Mn in 2025 and is expected to reach USD 1,965.2 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 13.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 804.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 13.60% | 2032 Value Projection: | USD 1,965.2 Mn |
Leadless pacemakers are advanced cardiac pacemakers that are implanted via femoral or trans-cutaneous access in the heart rather than through incisions in the chest. Unlike traditional pacemakers that are implanted under the skin in the chest with wires running from the pacemaker to the heart, leadless pacemakers are directly implanted in the heart and have no wires. They offer advantages such as reducing complications related to pacemaker leads and enabling more compatibility with magnetic resonance imaging (MRI) scans for patients. With advancements in miniaturization of electronics and improvements in battery life, leadless pacemakers are increasingly gaining popularity for treatment of bradycardia. Their global demand is projected to grow substantially in the coming years.
Market Dynamics:
The global leadless pacemakers market is driven by rising geriatric population worldwide that is susceptible to cardiovascular diseases, technological advancements enabling miniaturization of pacemaker systems, and benefits offered by leadless systems over traditional pacemakers such as reducing complications and enabling Magnetic Resonance Imaging, MRI compatibility. However, high cost of leadless pacemakers compared to traditional ones and issues regarding battery longevity act as restraints for the market. Introduction of completely leadless pacing systems with improved battery life by players presents a major growth opportunity. Regionally, developed markets in North America and Europe currently dominate the market but emerging countries in Asia Pacific are expected to provide high growth opportunities in the coming years.
Key Features of the Study:
This report provides in-depth analysis of the global leadless pacemakers market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global leadless pacemakers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, EBR Systems Inc., MicroPort Scientific Corporation, Biotronik SE & Co. KG, St. Jude Medical (now part of Abbott), Osypka AG, Lepu Medical Technology, Cardiac Rhythm Management (CRM), AtriCure Inc., Cook Medical, Sorin Group, Biotronik, and Neovasc Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global leadless pacemakers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leadless pacemakers market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2020 - 2032)
- Micra Transcatheter Pacing System
- Nanostim Leadless Pacemaker
- Other Leadless Pacemakers
- Type Insights (Revenue, USD Mn, 2020 - 2032)
- Single Chamber
- Dual Chamber
- End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals
- Ambulatory Surgical Centers
- long-term care facilities
- Others
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- EBR Systems Inc.
- MicroPort Scientific Corporation
- Biotronik SE & Co. KG
- Jude Medical (now part of Abbott)
- Osypka AG
- Lepu Medical Technology
- Cardiac Rhythm Management (CRM)
- AtriCure Inc.
- Cook Medical
- Sorin Group
- Biotronik
- Neovasc Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Leadless Pacemakers Market, By Product Type
- Global Leadless Pacemakers Market, By Type
- Global Leadless Pacemakers Market, By End User
- Global Leadless Pacemakers Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Leadless Pacemakers Market, By Product Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Micra Transcatheter Pacing System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Nanostim Leadless Pacemaker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Other Leadless Pacemakers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Leadless Pacemakers Market, By Type, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Single Chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Dual Chamber
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Leadless Pacemakers Market, By End User, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- long-term care facilities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Leadless Pacemakers Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- EBR Systems Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik SE & Co. KG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jude Medical (now part of Abbott)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Osypka AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lepu Medical Technology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardiac Rhythm Management (CRM)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AtriCure Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cook Medical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sorin Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neovasc Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
2025年全球脑部节律器市场报告2025年无导线心律调节器全球市场报告
2025 年至 2033 年心臟节律器市场（按类型、技术、适应症、最终用户和地区划分）2025 年全球植入式心臟心律调节器市场报告
心臟心律调节器市场：按产品类型、按植入性、按最终用户、按地区2025 年心律调节器全球市场报告2025 年心臟心律调节器全球市场报告心律调节器市场规模、份额和成长分析（按类型、技术、植入、应用、最终用户和地区）- 产业预测，2025-2032 年
无导线起搏器市场规模、份额、趋势分析报告：按起搏腔、最终用途、地区、细分市场预测，2025-2030 年心臟心律调节器市场规模、份额、成长分析，按类型、最终用户、地区 - 行业预测，2024-2031 年